| 2025-11-14 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-2.05美元,归母净利润-765.97万美元,同比去年增长0.98%
|
| 2025-11-07 |
详情>>
股本变动：
变动后总股本632.69万股
|
| 2025-09-24 |
复牌提示：
2025-09-24 10:07:48 停牌，复牌日期 2025-09-24 10:12:48
|
| 2025-08-13 |
详情>>
业绩披露：
2025年中报每股收益-1.24美元,归母净利润-420.78万美元,同比去年增长-0.32%
|
| 2025-05-15 |
详情>>
业绩披露：
2025年一季报每股收益-0.92美元,归母净利润-208.99万美元,同比去年增长-205.66%
|
| 2025-04-09 |
详情>>
业绩披露：
2024年年报每股收益-76.71美元,归母净利润-1310.66万美元,同比去年增长-27.9%
|
| 2024-12-13 |
详情>>
拆分方案：
每50.0000合并分成1.0000股
|
| 2024-11-15 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-3.75美元,归母净利润-773.55万美元,同比去年增长-18.5%
|
| 2024-10-23 |
股东大会：
将于2024-12-02召开股东大会
会议内容 ▼▲
- 1.To elect five nominees to our Board of Directors;
2.To approve the amendment of the Company’s certificate of incorporation, as amended, to effectuate a reverse stock split of Company’s outstanding shares of common stock, par value $0.0001 per share, at a ratio of no less than 1-for-10 and no more than 1-for-50, with such ratio to be determined at the sole discretion of the Company’s Board of Directors;
3.To ratify the appointment of Macias Gini & O’Connell LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024;
4.To approve adjournment of the Annual Meeting from time to time to a later date or dates, if necessary and appropriate, under certain circumstances, including for the purpose of soliciting additional proxies in favor one or more of the foregoing proposals, in the event the Company does not receive the requisite stockholder vote to approve such proposal(s) or establish a quorum;
5.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2024-08-19 |
详情>>
业绩披露：
2024年中报每股收益-2.46美元,归母净利润-419.42万美元,同比去年增长-284.05%
|
| 2024-08-19 |
财报披露：
美东时间 2024-08-19 盘后发布财报
|
| 2024-06-03 |
详情>>
业绩披露：
2023年年报每股收益-20.46美元,归母净利润-1024.71万美元,同比去年增长73.06%
|
| 2024-05-20 |
详情>>
业绩披露：
2024年一季报每股收益-0.46美元,归母净利润-68.37万美元,同比去年增长88.86%
|
| 2023-11-21 |
股东大会：
将于2023-12-22召开股东大会
会议内容 ▼▲
- 1.To elect five (5) nominees to our board of directors (the “Election of Directors Proposal”);
2.To approve amendments to the Company’s 2020 Omnibus Incentive Stock Plan (the “2020 Plan”) to increase the aggregate number of shares of Common Stock authorized for issuance under the 2020 Plan to 200,000 shares (the “2020 Plan Amendment Proposal”);
3.To approve, for purposes of complying with Nasdaq Listing Rule Section 5635(c), of the issuance of shares of Common Stock to our Chief Executive Officer pursuant to a Performance Stock Award Agreement (the “CEO Performance Agreement Proposal”);
4.To ratify the appointment of Macias Gini & O’Connell LLP (“MGO”) as our independent registered public accounting firm for the fiscal year ending December 31, 2023 (the “Auditor Ratification Proposal”);
5.To approve adjournment of the Annual Meeting from time to time to a later date or dates, if necessary and appropriate, under certain circumstances, including for the purpose of soliciting additional proxies in favor one or more of the foregoing proposals, in the event the Company does not receive the requisite stockholder vote to approve such proposal(s) or establish a quorum (the “Adjournment Proposal”);
6.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2023-11-14 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-17.5美元,归母净利润-652.81万美元,同比去年增长70.68%
|
| 2023-08-22 |
详情>>
拆分方案：
每25.0000合并分成1.0000股
|
| 2023-08-21 |
详情>>
业绩披露：
2023年中报每股收益-0.18美元,归母净利润-109.21万美元,同比去年增长93.71%
|
| 2023-07-19 |
股东大会：
将于2023-08-21召开股东大会
会议内容 ▼▲
- 1.To approve the amendment of the Company’s Sixth Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company’s outstanding common stock at an exchange ratio between 1-for-2.5 to 1-for-50, as determined by the Company’s Board of Directors;
2.The postponement or adjournment of the Special Meeting from time to time, to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt Proposal No. 1 or establish a quorum.
|
| 2022-11-04 |
详情>>
拆分方案：
每100.0000合并分成1.0000股
|
| 2022-09-14 |
股东大会：
将于2022-10-13召开股东大会
会议内容 ▼▲
- 1.To elect five (5) nominees to our board of directors;
2.To approve an amendment to the Company’s Sixth Amended and Restated Certificate of Incorporation to increase the number of authorized shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) from 200,000,000 to 1,000,000,000, and in conjunction therewith, to increase the aggregate number of authorized shares to 1,010,000,000 shares;
3.To approve amendments to the Company’s 2020 Omnibus Incentive Stock Plan (the “2020 Plan”) to increase the number of shares of Common Stock authorized for issuance under the 2020 Plan by 40,000,000 shares;
4.To approve for purposes of complying with Nasdaq Listing Rule Section 5635(d) the issuance of additional shares of Common Stock underlying convertible notes issued by us in October and November 2021 without giving effect to the exchange cap in such senior secured convertible notes in an amount that may be equal to or exceed 20% of our Common Stock outstanding immediately prior to the issuance of such senior secured convertible notes;
5.To approve the issuance of more than 20% of our Common Stock pursuant to a purchase agreement with Oasis Capital, LLC, for purposes of Nasdaq Listing Rule 5635(d);
6.To approve the amendment of the Company’s Sixth Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company’s outstanding common stock at an exchange ratio between 1-for-50 and 1-for-150, as determined by the Company’s Board of Directors;
7.To approve, for purposes of complying with Nasdaq Listing Rule 5635(a), the issuance of shares of common stock as partial consideration for our acquisition of all of the outstanding membership interests of Sunnyside, LLC;
8.To ratify the appointment of dbbmckennon as our independent registered public accounting firm for the fiscal year ending December 31, 2022;
9.To approve the adjournment of the Meeting by the chairman thereof to a later date, if necessary, under certain circumstances, including for the purpose of soliciting additional proxies in favor of the foregoing Proposals, in the event the Company does not receive the requisite stockholder vote to approve the Proposals;
10.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|